Detection, assessment, management and prevention of delirium in hospice in-patients Mental and Behavioural Disorders Delirium, unspecified
Conditions
Interventions
Each hospice will be supported by the study team to use the CLECC-Pal plan to implement guideline-adherent delirium care over a minimum 12-week period. Hospices who wish to continue following this per
Sponsors
University of Hull
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Work package 1 (co-design): Not applicable Work package 2 (feasibility study): In-patients admitted to study hospices Work package 3 (process evaluation): Hospice staff (healthcare assistants, nurses, allied health professionals, doctors, volunteers, care managers and executive board members) and volunteers directly and/or indirectly involved with the delivery of care
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility will be assessed by: 1. Number of relevant hospice staff engaging and maintaining engagement with CLECC-Pal during the 12-week intervention period 2. Ability to collect high validity, anonymised delirium outcome data from clinical records using an expanded version of a chart based tool developed by Inouye et al. at baseline and 12 weeks 3. Cost data in relation to the number of staff hours engaged in CLECC-Pal activities during the 12-week intervention period 4. Variability in delirium day measures (to calculate sample size for a subsequent national study) at baseline and at 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom
Contacts
Public ContactGillian Jackson
Outcome results
None listed